Earnings Feed
Start Free
Home/Insiders/Smith Sean Michael
SS
SEC Insider//CIK 0001914769

Smith Sean Michael

CIK 00019147691 companySEATTLE, WA
SEC Profile

Transactions

11

Companies

1

Filings

5

CIK

0001914769

Recent Transactions

11 trades
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2023-08-11$0.62/sh−1,323→ 21,637 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2023-08-10+5,000→ 22,960 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2023-08-10−5,000→ 0 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2023-02-02$0.60/sh−3,316→ 15,960 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2023-02-01+12,500→ 19,276 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2023-02-01−12,500→ 12,500 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2022-08-10$0.99/sh−1,655→ 6,776 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2022-08-10−5,000→ 5,000 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2022-08-10+5,000→ 8,431 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2022-08-02+150,000→ 150,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2022-03-02+80,000→ 80,000 total

Companies

1

Recent Filings

5

Address

C/O NEOLEUKIN THERAPEUTICS, INC. 188 EAST BLAINE STREET, #450

SEATTLE, WA, 98102

View on SEC.gov